Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3441]

Geriatric oncology in resource-limited settings

Dr Enrique Soto Perez de Celis - National Institute of Medical Sciences, Mexico...

Geriatric oncology in resource-limited settings ( Dr Enrique Soto Perez de Celis - National Institute of Medical Sciences, Mexico City, Mexico )

Updates on HR-positive HER2-negative breast cancer

Dr Mariana Chavez - MD Anderson Cancer Center, Houston, USA

Updates on HR-positive HER2-negative breast cancer ( Dr Mariana Chavez - MD Anderson Cancer Center, Houston, USA )

Haematology malignancies and cellular therapy

Dr Hugo Fernandez - Moffitt Cancer Center, Tampa, USA

Haematology malignancies and cellular therapy ( Dr Hugo Fernandez - Moffitt Cancer Center, Tampa, USA )

Hodgkin’s and non-Hodgkin’s lymphomas (NHL)

Dr Jose Sandoval Sus - Moffitt Malignant Hematology & Cellular Therapy at...

Hodgkin’s and non-Hodgkin’s lymphomas (NHL) ( Dr Jose Sandoval Sus - Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, Florida, USA )

GIST tumours and soft tissue sarcomas

Dr Atif Hussein - Memorial Healthcare System, Florida, USA

GIST tumours and soft tissue sarcomas ( Dr Atif Hussein - Memorial Healthcare System, Florida, USA )

Challenges in interpreting comprehensive biomarker testing and a few paths to...

Dr Howard Jack West - City of Hope Comprehensive Cancer Center, California, USA

Challenges in interpreting comprehensive biomarker testing and a few paths to address them ( Dr Howard Jack West - City of Hope Comprehensive Cancer Center, California, USA )

Updates on triple-negative breast cancer and immunotherapy

Dr Avan Armaghani - Moffitt Cancer Center, Tampa, USA

Updates on triple-negative breast cancer and immunotherapy ( Dr Avan Armaghani - Moffitt Cancer Center, Tampa, USA )

Updates in melanoma and skin cancers

Dr Sanjiv Agarwala - St. Luke’s Cancer Center, Philadelphia, USA

Updates in melanoma and skin cancers ( Dr Sanjiv Agarwala - St. Luke’s Cancer Center, Philadelphia, USA )

Gynaecological cancer: New targets and immunotherapy developments

Dr Mark Shahin - Jefferson Health, Philadelphia, USA

Gynaecological cancer: New targets and immunotherapy developments ( Dr Mark Shahin - Jefferson Health, Philadelphia, USA )

Molecular oncology and translational medicine

Dr Gregg Fields - Florida Atlantic University, Florida, USA

Molecular oncology and translational medicine ( Dr Gregg Fields - Florida Atlantic University, Florida, USA )

Immunotherapy in NSCLC: Adjuvant and neoadjuvant clinical scenarios

Dr Luis Raez - Memorial Healthcare System, Florida, USA

Immunotherapy in NSCLC: Adjuvant and neoadjuvant clinical scenarios ( Dr Luis Raez - Memorial Healthcare System, Florida, USA )

Potential benefit to response rates from trastuzumab added to perioperative...

Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of...

Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC ( Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of the EORTC Gastric Cancer Task Force )

More from ecancer